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SUMMARY

Intellectual disability (ID) is a prevalent developmental disorder of cognition that remains incurable.
Here, we report that knockdown of the X-linked
ID (XLID) protein polyglutamine-binding protein 1
(PQBP1) in neurons profoundly impairs the morphogenesis of the primary cilium, including in the mouse
cerebral cortex in vivo. PQBP1 is localized at the
base of the neuronal cilium, and targeting its WW
effector domain to the cilium stimulates ciliary
morphogenesis. We also find that PQBP1 interacts
with Dynamin 2 and thereby inhibits its GTPase activity. Accordingly, Dynamin 2 knockdown in neurons
stimulates ciliogenesis and suppresses the PQBP1
knockdown-induced ciliary phenotype. Strikingly, a
mutation of the PQBP1 WW domain that causes
XLID disrupts its ability to interact with and inhibit
Dynamin 2 and to induce neuronal ciliogenesis.
These findings define PQBP1 and Dynamin 2 as components of a signaling pathway that orchestrates
neuronal ciliary morphogenesis in the brain.
INTRODUCTION
Intellectual disability (ID) is a common developmental disorder
with a prevalence of 1%–3% (Bhasin et al., 2006; Larson et al.,
2001). No effective treatments are available and thus there is
an urgent need to better understand the molecular pathogenesis
of ID. Human genetic studies have led to the identification of
many genes whose mutations cause ID (Chelly et al., 2006;
Ropers, 2010). However, the functions of ID proteins largely
remain to be elucidated.
Approximately 30%–50% more males than females are
affected with ID, presumably reflecting mutations on the X chro-

mosome. Mutations in more than 90 genes on the X chromosome have been associated with ID (Chiurazzi et al., 2008;
Gécz et al., 2009). In many cases, XLID mutations cause syndromes that include constellations of symptoms and signs
outside the nervous system. The heterogeneity of genes and
associated ID syndromes raises the question as to whether common or disparate pathogenic signaling mechanisms underlie ID.
To begin to address this fundamental question, we need to gain a
better understanding of the functions of ID-associated proteins.
Notably, a substantial portion of XLID genes encode proteins
that are predicted to localize in the nucleus (Chiurazzi et al.,
2008), providing a starting point for investigating the cell-intrinsic
regulation of neuronal development and function by these XLID
proteins.
Deregulation of neuronal morphogenesis represents a prominent pathological feature in ID. Impaired development of dendrites and dendritic spines may represent an important aspect
of neuronal pathology in the brains of ID patients (Kaufmann
and Moser, 2000; Purpura, 1974), supporting the concept that
deregulation of neuronal connectivity contributes to the pathogenesis of ID. Consistent with these studies, XLID proteins regulate the development of dendrite arbors and the formation of
dendritic spines in neurons (Irwin et al., 2000; Iwase et al.,
2007). These observations raise the question as to whether
XLID proteins regulate other aspects of neuronal morphogenesis.
The primary cilium represents an intriguing organelle that has
received attention in recent years (Gerdes et al., 2009; Singla and
Reiter, 2006). Primary cilia play critical roles in early embryonic
development and organogenesis in vertebrates by providing
a unique cellular domain that facilitates signal transduction
in response to morphogens and growth factors (Goetz and
Anderson, 2010; Lancaster and Gleeson, 2009). Disruption of
the formation or function of primary cilia causes a heterogeneous
group of ciliopathies, including Bardet-Biedl syndrome (BBS),
Meckel-Gruber syndrome, and Joubert syndrome, which are
characterized by overlapping clinical presentations of polycystic
kidney, retinal degeneration, cerebellar atrophy, and, notably, ID
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Figure 1. A Targeted RNAi Screen of XLID
Genes in Ciliary Morphogenesis in Neurons
Hippocampal neurons were transfected with an
RNAi plasmid encoding shRNAs targeting the
indicated XLID gene or the control U6 plasmid
together with the GFP expression plasmid, and
subjected to immunocytochemistry at DIV5 using
the AC3 and GFP antibodies. Knockdown of each
protein by cognate shRNAs was validated (Figures
2A and S1). Knockdown of PQBP1 consistently
reduced the percentage of neurons harboring a
primary cilium (p < 0.05; ANOVA). A total of 2,646
neurons were quantified.
See also Figure S1.

(Badano et al., 2006; Hildebrandt et al., 2011). These observations support the hypothesis that impairment of neuronal
ciliogenesis might represent an important feature in the pathogenesis of developmental cognitive disorders. Growing evidence suggests that the primary cilium functions as a signaling
center in neurons (Lee and Gleeson, 2011; Louvi and Grove,
2011). Several G protein coupled receptors (GPCRs) are localized within the neuronal cilium, including the somatostatin receptor 3 (SSTR3), melanin concentrating hormone receptor 1
(MCHR1), serotonin receptor 6 (5HTR6), and dopamine receptors (Domire et al., 2011; Hamon et al., 1999; Händel et al.,
1999; Marley and von Zastrow, 2010). In addition, the 12-transmembrane enzyme adenylyl cyclase 3 (AC3), which generates
cyclic AMP in response to activation by GPCRs, is localized in
the membrane of the neuronal cilium (Bishop et al., 2007).
Mice in which the AC3 or SSTR3 gene is disrupted have defects
in object recognition memory, suggesting an important role for
cilia in regulating signaling events that are critical for cognitive
function (Einstein et al., 2010; Wang et al., 2011). Thus, the
primary cilium may play a key role in neuronal signaling and
brain function.
The fundamental architecture of the primary cilium includes
microtubule bundles extending from the basal body and an
encasing ciliary membrane on which the ciliary receptors
localize. Components of the primary cilium are sorted and
trafficked by the intraflagellar transport (IFT) system and ciliary
membrane trafficking, which control the formation and function
of the cilium (Nachury et al., 2010; Pedersen et al., 2008).
Although the mechanisms that control ciliogenesis in nonneuronal cells have been intensely investigated, the mechanisms
that specifically orchestrate the development and morphogenesis of the neuronal cilium remain poorly understood.
In this study, we identify a function for the major XLID protein
polyglutamine-binding protein 1 (PQBP1) in the morphogenesis
of the primary cilium in postmitotic neurons. Knockdown of
PQBP1 profoundly impairs the formation of the primary cilium
in hippocampal neurons and the mouse cerebral cortex in vivo.
PQBP1 is localized at the base of the neuronal cilium as well
as the nucleus, and targeting the PQBP1 WW effector domain
to the cilium induces ciliary development. We also identify the
protein Dynamin 2 as a cytoplasmic target of PQBP1 in neurons.
PQBP1 interacts with Dynamin 2 and thereby inhibits the
GTPase activity of Dynamin 2. Accordingly, Dynamin 2 knockdown stimulates ciliary morphogenesis and suppresses the

PQBP1 knockdown-induced loss of cilia in neurons. Importantly,
we also find that a mutation of the PQBP1 WW domain that
causes XLID deregulates PQBP1-Dynamin 2 signaling and
consequent ciliary morphogenesis in neurons. The identification
of the PQBP1-Dynamin 2 signaling link as a critical regulator of
neuronal ciliary development in the brain bears potential implications for our understanding of the mechanisms underlying ID.
RESULTS
To investigate the functions of XLID proteins in ciliary morphogenesis, we performed a targeted RNAi screen of XLID genes
in primary rat hippocampal neurons. We focused our attention
on genes encoding proteins predicted to localize in the nucleus
and regulate transcription or RNA processing. Knockdown of
each XLID protein by cognate short hairpin RNAs (shRNAs)
was validated (see Figures 2A and S1F).
To visualize the primary cilium in hippocampal neurons, we
performed immunocytochemical analyses using an antibody
that recognizes adenylyl cyclase 3 (AC3). A single bar-shaped
ciliary structure extending from the soma of hippocampal neurons was observed (Figure S1A). The base of the cilium was
contiguous with the centrosome, with the latter identified by
expression of Centrin-GFP (Figure S1A). Although the nonneuronal ciliary marker acetylated tubulin was expressed within the
AC3-positive cilia in neurons, it was also detected throughout
the cytoplasm in neurons (Figure S1B). The neuronal cilium
also displayed expression of somatostatin receptor 3 (SSTR3)
and melanin concentration hormone receptor 1 (MCHR1; Figures S1C and S1D). These data establish that primary hippocampal neurons harbor primary cilia. The percentage of hippocampal
neurons bearing a cilium increased as neurons matured between
2 days in vitro (DIV2) and DIV7 (Figure S1E).
To assess the effect of knockdown of nuclear XLID proteins on
ciliary morphogenesis, we transfected hippocampal neurons
with RNAi plasmids targeting each XLID protein together with a
GFP expression plasmid at DIV1, and subjected neurons at
DIV5 to immunocytochemical analyses using the AC3 and GFP
antibodies. Strikingly, we found that knockdown of the XLID
protein PQBP1, using two shRNAs targeting distinct regions of
PQBP1 messenger RNA (mRNA), consistently and substantially
reduced the percentage of neurons harboring a primary cilium
(Figures 1, 2A–2C, and S2A). More than 70 affected individuals
from more than 20 families with PQBP1 mutations have been
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reported to exhibit ID (Germanaud et al., 2011; Jensen et al.,
2011; Rejeb et al., 2011; Sheen et al., 2010; Stevenson et al.,
2005). PQBP1 is a predominantly nuclear protein that regulates
transcription and splicing (Tapia et al., 2010; Waragai et al.,
1999; Zhang et al., 2000), but the pathophysiologically relevant
functions of PQBP1 in XLID have remained unknown. Therefore,
we further characterized the role of PQBP1 in the development of
the primary cilium in neurons. Besides AC3 staining, expression
of the intraflagellar transport protein IFT88 fused to GFP (GFPIFT88) was used as another ciliary marker to interrogate the function of PQBP1 (Figures 2D and S2B). IFT88 is a component of the
kinesin-dependent anterograde ciliary trafficking protein complex IFTB (Gerdes et al., 2009). PQBP1 knockdown reduced
the number of neurons bearing a GFP-IFT88-positive cilium (Figures 2D and 2E). Likewise, PQBP1 knockdown reduced the
number of neurons bearing an SSTR3-positive cilium (Figure S2C). These observations support the conclusion that
PQBP1 is required for ciliogenesis in hippocampal neurons. In
contrast, knockdown of PQBP1 had little or no effect on ciliogenesis in NIH 3T3 fibroblasts and Madin-Darby canine kidney
(MDCK) epithelial cells in the presence or absence of serum (Figures S2D–S2G). Consistent with these results, in contrast to
PQBP1’s localization at the primary cilium in neurons (see
below), PQBP1 failed to localize to the cilium in NIH 3T3 and
MDCK cells in the presence or absence of serum (Figures
S2H–S2K). Taken together, these data suggest that PQBP1 promotes ciliogenesis selectively in neurons.
We next determined the function of PQBP1 in the brain in vivo.
We used an in utero electroporation method to transfect embryonic day 15.5 (E15.5) mouse pups with the PQBP1 RNAi or control U6 RNAi plasmid. Animals were sacrificed at postnatal day
10 (P10) and the cerebral cortex was subjected to immunohistochemical analyses using the AC3 antibody. In these experiments, neurons that had migrated from the ventricular zone
and reached the cortical plate extended a primary cilium (Figures
2F and S2L). Over 70% of neurons in the cerebral cortex in pups
transfected with the control plasmid harbored a primary cilium
(Figure 2G). By contrast, only 45% neurons in the cerebral cortex
in PQBP1 knockdown animals harbored a primary cilium (Figure 2G). These data suggest that the XLID protein PQBP1 plays
a critical role in the morphogenesis of the neuronal cilium in the
mouse brain in vivo.
The identification of a critical role for PQBP1 in ciliary morphogenesis in the mammalian brain led us next to investigate the
molecular basis of PQBP1’s function. We first characterized
the subcellular localization of PQBP1 in neurons. Although overexpressed PQBP1 was predominantly localized in the nucleus
(data not shown), in addition to its expression in the nucleus,
PQBP1 was localized at the cilium in hippocampal neurons
(Figures 3A, 3B, S3A, and S3D). PQBP1 immunoreactivity was
contiguous with the centrosome (Figure 3A) and was often
observed at the base of the primary cilium (Figure 3B). Ciliary
PQBP1 immunoreactivity was blocked by preabsorption with
PQBP1 protein (Figure S3B) and was reduced upon PQBP1
knockdown (Figure S3C), demonstrating the specificity of the
PQBP1 immunoreactive signal. Biochemical fractionation of hippocampal neurons revealed that the cytoplasmic fraction contained PQBP1 (Figure 3C). Further fractionation of hippocampal

neuron lysates with sucrose gradient demonstrated that PQBP1
cofractionated with the centrosomal marker gTubulin (Figure 3D).
Together, these data reveal that in addition to expression in the
nucleus, PQBP1 is localized at the base of the primary cilium in
neurons.
We next characterized the function of PQBP1 outside of the
nucleus in regulating ciliogenesis. We sought to identify proteins
that interact with PQBP1 specifically in the cytoplasm but not the
nucleus. Therefore, we performed glutathione S-transferase
(GST) pull-down analyses using a GST-PQBP1 fusion protein
or the control protein GST as bait and nuclear or cytoplasmic
lysates of cortical neurons as the source of protein, followed
by high-salt elution, SDS-PAGE, and Coomassie staining (Figures 4A and S4A). Notably, the cytoplasmic fraction of cortical
neuron lysates contained centrosomal and ciliary proteins (Figure S4B). We found four protein bands in the cytoplasmic fraction and ten protein bands in the nuclear fraction that specifically
associated with GST-PQBP1 but not GST (Figure 4A). All of the
visible protein bands that coprecipitated with GST-PQBP1
were absent in a pull-down assay using a GST-PQBP1 protein
containing a mutation at critical amino acids in the WW domain
(GST-PQBP1 W75A P78G; Figures 4A and 4B), suggesting that
the WW domain is required for the interaction. PQBP1-associated proteins were identified by mass spectrometry (Figure 4C).
Consistent with PQBP1’s reported function in RNA splicing
(Llorian et al., 2005; Tapia et al., 2010; Zhang et al., 2000), premRNA processing factors were among the nuclear proteins
that interacted with PQBP1, validating the utility of the GST
pull-down assay for identifying PQBP1-interacting proteins.
Importantly, we identified Dynamin 2 in the cytoplasmic fraction
as a PQBP1-interacting protein (Figure 4C). In coimmunoprecipitation analyses, endogenous PQBP1 formed a complex
with endogenous Dynamin 2 in the cytoplasmic fraction of
P6 brain lysates (Figure 4D). Altogether, these data suggest
that Dynamin 2 represents a cytoplasmic interaction partner
of PQBP1.
PQBP1 interacted with all three Dynamin isoforms in the cytoplasmic fraction of cortical neurons (Figure 4C). Notably, PQBP1
interacted selectively with Dynamin 1 and 2 in GST pull-down
assays (Figure S4C). We focused on Dynamin 2 because it is
reported to localize to the centrosome (Liu et al., 2007; Thompson et al., 2004). Dynamin 2 cofractionated with the centrosomal
marker gTubulin in fractionated lysates of neurons (Figures 4E
and S4D), corroborating the conclusion that Dynamin 2 is localized at the centrosome in neurons. In addition, a Dynamin
2-GFP fusion protein partially colocalized with the centrosomal marker Pericentrin (Figure S4E) and PQBP1 in neurons
(Figure S4F).
We performed structure-function analyses to identify the
structural determinants that mediate PQBP1’s interaction with
Dynamin 2. Deletion of PQBP1’s alternatively spliced exon 4,
containing amino acids 98–192, did not impair interaction with
Dynamin 2 (Figure 4F). Further deletion of the entire C-terminal
region (98–265 aa) leaving only the WW domain (1–97 aa) maintained the ability of PQBP1 to form a complex with Dynamin 2,
although the interaction was modestly diminished (Figure 4F).
These results suggest that the PQBP1 WW domain is sufficient
to interact with Dynamin 2. The WW domain protein Pin1 failed
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Figure 2. PQBP1 Is Required for Ciliogenesis in Primary Hippocampal Neurons and the Cerebral Cortex In Vivo
(A) Lysates of 293T cells transfected with the Flag-PQBP1 expression plasmid along with the PQBP1 RNAi or control U6 RNAi plasmid were immunoblotted with
the Flag or Actin antibodies, the latter to serve as loading control.
(B) Hippocampal neurons transfected with the PQBP1 RNAi or control U6 RNAi plasmid together with the GFP expression plasmid were subjected to immunocytochemistry using the GFP and AC3 antibodies. Representative neurons are shown. Arrow indicates the primary cilium. The outline of transfected neurons is
shown with a white line in the lower panels. Scale bar, 5 mm.
(C) The percentage of neurons harboring a primary cilium was significantly reduced upon PQBP1 knockdown (p < 0.01; ANOVA). A total of 1,240 neurons were
counted.
(D) Hippocampal neurons transfected with the PQBP1 RNAi or control U6 RNAi plasmid together with a GFP-IFT88 expression plasmid were subjected to immunocytochemistry with the GFP and AC3 antibodies. Representative neurons are shown. Arrow indicates the primary cilium. The AC3 signal is shifted. Scale bar, 5 mm.
(legend continued on next page)
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A

C

Figure 3. PQBP1 Localizes at the Base of
the Cilium and Centrosome

B

(A and B) Hippocampal neurons were subjected to
immunocytochemistry with the PQBP1 antibody
together with the Pericentrin antibody (A), or AC3
antibody (B). Arrows indicate PQBP1 immunoreactivity at the cilium. Scale bar, 5 mm.
(C) Cytoplasmic and nuclear fractions isolated
from rat cortical neurons were immunoblotted
using the PQBP1, 14-3-3, and SnoN antibodies.
14-3-3 and SnoN served as cytoplasmic and
nuclear markers, respectively.
(D) Centrosomal fractions prepared from rat
cortical neuron lysates were immunoblotted using
the PQBP1, gTubulin, and SnoN antibodies.
PQBP1 and gTubulin cofractionated, suggesting
that PQBP1 is present at the centrosome. SnoN
served as a negative control.
See also Figure S3.

D

to bind Dynamin 2 (Figure 4F), suggesting that Dynamin 2 interacts specifically with the PQBP1 WW domain.
We next determined the requirement for the WW domain
in PQBP1’s interaction with Dynamin 2. Mutation of two
conserved amino acids in the WW domain in full-length
PQBP1 (W75A P78G) abolished PQBP1’s interaction with Dynamin 2 (Figure 4F), suggesting that the WW domain is essential
for PQBP1’s association with Dynamin 2. The missense mutation A194G leading to Y65C substitution within the PQBP1
WW domain causes the Golabi-Ito-Hall ID syndrome (Lubs
et al., 2006). Importantly, the Y65C mutation blocked the ability
of PQBP1 to interact with Dynamin 2 (Figure 4F), suggesting
that the interaction of PQBP1 with Dynamin 2 may be deregulated in XLID.
We next identified the Dynamin 2 domain that interacts with
PQBP1. A Dynamin 2 protein in which the GTPase active site
Lys44 was replaced with alanine (K44A) formed a complex
with PQBP1 (Figure 4G), suggesting that GTPase activity is not
required for Dynamin 2’s interaction with PQBP1. In contrast, a
Dynamin 2 mutant protein lacking the C-terminal proline/arginine-rich domain (DPRD) failed to form a complex with PQBP1,
suggesting that the PRD is required for Dynamin 2’s interaction
with PQBP1.

Because Dynamin’s GTPase activity is
regulated by protein-protein interactions
through its PRD (Schmid and Frolov,
2011), we asked whether PQBP1 might
modulate the GTPase activity of Dynamin 2. Remarkably, the GTPase activity
of Dynamin 2 measured in an in vitro
assay was substantially attenuated in the presence of PQBP1
(Figure 4H). In structure-function analyses, removal of exon 4
or the entire C-terminal domain had little or no effect on the ability
of PQBP1 to inhibit Dynamin 2’s GTPase activity (Figure 4H),
suggesting that the PQBP1 WW domain is sufficient to inhibit
Dynamin 2 activity. In contrast, mutation of the conserved residues within the WW domain (W75A P78G) impaired the ability
of PQBP1 to inhibit Dynamin 2’s GTPase activity (Figure 4H).
Importantly, the Golabi-Ito-Hall syndrome mutation Y65C also
impaired PQBP1’s ability to inhibit the GTPase activity of Dynamin 2 (Figure 4H). Taken together, our results demonstrate that
PQBP1 interacts via its WW domain with Dynamin 2 and thereby
inhibits the GTPase activity of Dynamin 2.
Because the WW domain of PQBP1 is sufficient to inhibit
Dynamin 2 activity, we employed a gain-of-function approach
to target the PQBP1 WW domain to the cilium and interrogate
its function in ciliary morphogenesis. The protein IFT20, a
component of a protein complex that mediates anterograde
ciliary trafficking, localizes to the cilium and basal body as well
as the Golgi apparatus (Follit et al., 2006). To localize the
PQBP1 WW domain at the cilium, we expressed a protein in
which the WW domain was fused to IFT20 (IFT20-WW; Figures
S4H and S4I). Expression of IFT20 alone had little or no effect

(E) The percentage of neurons bearing a GFP-IFT88-positive cilium was significantly reduced upon PQBP1 knockdown (p < 0.05; ANOVA). A total of 244 neurons
were counted.
(F) Mouse embryos were electroporated with the PQBP1 RNAi or control U6 RNAi plasmid together with the GFP expression plasmid and subjected to
immunohistochemistry at P10 with the GFP and AC3 antibodies. Arrows indicate the primary cilium. PQBP1 RNAi reduced the number of neurons bearing a
cilium. Scale bar, 5 mm.
(G) The percentage of neurons harboring a primary cilium was significantly reduced in PQBP1 knockdown animals as compared with the U6 control plasmid
(p < 0.01; t test). A total of 355 neurons were quantified.
See also Figure S2.
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Figure 4. PQBP1 Forms a Complex with Dynamin 2 and Inhibits the GTPase Activity of Dynamin 2
(A) Proteins coprecipitated with GST-PQBP1, GST-PQBP1 W75A P78G, or GST were analyzed by SDS-PAGE and Coomassie brilliant blue staining. Numbers
and arrowheads indicate bands analyzed by mass spectrometry.
(B) Schematic of the PQBP1 protein domain structure. The WW domain, 7 aa repeat, DR/ER repeat, and nuclear localization signal (NLS) are indicated.
(C) Identity of PQBP1-associated proteins in cytoplasmic and nuclear fractions of cortical neuron lysates. Numbers in parentheses indicate the protein
band in (A).
(D) The cytoplasmic fraction of P6 rat brain lysate was immunoprecipitated with the PQBP1 antibody or rabbit IgG and immunoblotted with the Dynamin or PQBP1
antibody. Asterisk denotes a nonspecific band.
(E) Centrosomal fractions isolated from rat cortical neurons were immunoblotted using the Dynamin 2, gTubulin, and GM130 antibodies. Dynamin 2 and gTubulin
cofractionated, suggesting that Dynamin 2 is present at the centrosome. GM130 served as a negative control.
(F) Lysates of rat cortical neurons subjected to pull-down assay with GST, GST-PQBP1, GST-PQBP1 DExon4 (D98-192), GST-PQBP1 WW (1 97), GST-PQBP1
W75A P78G, GST-PQBP1 Y65C, or GST-Pin1, and immunoblotted with Dynamin 2 antibody or stained with Ponceau S.
(legend continued on next page)
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on ciliary morphogenesis in hippocampal neurons (Figure 4I). By
contrast, expression of the IFT20-WW fusion protein substantially increased the percentage of neurons bearing a neuronal
cilium (Figure 4I). Remarkably, the Golabi-Ito-Hall ID mutation
Y65C abolished the ability of IFT20-WW to promote ciliary
morphogenesis (Figure 4I). Expression of the PQBP1 WW
domain in the nucleus, which we achieved by fusing the WW
domain to the nuclear localizing signal (NLS-WW), failed to promote ciliogenesis in neurons (Figure S4G), suggesting that
PQBP1 operates outside of the nucleus to promote the formation
of the primary cilium in neurons. These data suggest that localizing the PQBP1 WW domain to the cilium stimulates ciliary
morphogenesis and that impairment of this function may play a
pathogenic role in the Golabi-Ito-Hall ID syndrome.
To determine the role of Dynamin 2 in ciliary morphogenesis,
we induced Dynamin 2 knockdown in hippocampal neurons
using two shRNAs targeting distinct regions of Dynamin 2
mRNA (Figure 5A). Since PQBP1 inhibits Dynamin 2 activity, inhibition of Dynamin 2 would be predicted to induce the formation
of the neuronal cilium. Consistent with this prediction, Dynamin 2
knockdown promoted ciliary morphogenesis in hippocampal
neurons (Figures 5B, 5C, and S5A). The percentage of neurons
harboring a primary cilium was increased and the cilium was
substantially longer in Dynamin 2 knockdown neurons (Figure 5C), suggesting that Dynamin 2 inhibits the formation and
growth of the primary cilium in neurons. In epistasis analyses,
Dynamin 2 knockdown suppressed the PQBP1 knockdowninduced phenotype of loss of cilia (Figure 5D), suggesting that
Dynamin 2 operates downstream of PQBP1 in the control of
ciliary morphogenesis. Consistently, knockdown of Dynamin 2
had little or no effect on the localization of PQBP1 at the cilium
in neurons (Figure S5B).
We next characterized Dynamin 2’s function in neuronal ciliary
development in vivo. Dynamin 2 RNAi induced by in utero electroporation led to impaired migration of cortical neurons, suggesting a function for Dynamin 2 in neuronal precursor cells or
immature neurons (data not shown). This phenotype precluded
the use of in utero electroporation to assess the role of Dynamin
2 in ciliary morphogenesis in mature neurons. To overcome this
limitation, we induced Dynamin 2 knockdown in the cerebral cortex in neonatal mice using a lentiviral approach. We found a
3-fold increase in the percentage of neurons in the cerebral cortex in Dynamin 2 knockdown animals that had a cilium longer
than 5 mm compared with control animals (Figures 5E and 5F),
demonstrating that Dynamin 2 inhibits ciliary morphogenesis
in vivo. Together, these data reveal a function for Dynamin 2 in
the control of ciliogenesis in the developing rodent brain. Collectively, our study defines a XLID-deregulated PQBP1-Dynamin 2
signaling link that orchestrates ciliary morphogenesis in postmitotic neurons in the brain.

DISCUSSION
In this study, we have discovered a signaling link between the
major XLID protein PQBP1 and the GTPase Dynamin 2 that regulates the formation of the primary neuronal cilium in the brain
(see model in Figure 5G). PQBP1 is localized at the base of the
cilium and plays an important role in ciliogenesis in primary
rodent hippocampal neurons and cortical neurons in the mouse
brain in vivo. We have also identified the molecular basis by
which PQBP1 drives the morphogenesis of the neuronal cilium.
PQBP1 forms a complex with the GTPase Dynamin 2 and
thereby inhibits its GTPase activity. Knockdown of Dynamin 2
stimulates the formation of the neuronal cilium and suppresses
PQBP1 knockdown-induced loss of cilia in neurons. A patientspecific mutation of the PQBP1 WW domain that causes XLID
impairs the ability of PQBP1 to interact with and thereby inhibit
Dynamin 2 and to promote ciliary morphogenesis. Taken
together, our findings define PQBP1-Dynamin 2 signaling as a
mechanism that orchestrates neuronal ciliary morphogenesis in
the brain, with potential implications for the pathogenesis of ID.
The identification of a function for PQBP1 in ciliary morphogenesis in postmitotic neurons may shed light on the pathogenesis of XLID caused by mutations of the PQBP1 gene in
syndromic as well as nonsyndromic ID (Germanaud et al.,
2011; Jensen et al., 2011; Rejeb et al., 2011; Sheen et al.,
2010; Stevenson et al., 2005). Mutations of PQBP1 cause recessive XLID, suggesting that these disorders result from loss of
PQBP1 function. Accordingly, several XLID-associated PQBP1
mutations cause premature termination and downregulation of
PQBP1 protein due to nonsense-mediated RNA decay (Musante
et al., 2010). Notably, a missense mutation in Golabi-Ito-Hall
syndrome alters a conserved residue within the WW domain of
PQBP1 (Lubs et al., 2006). These observations highlight the
importance of the WW domain in the pathogenesis of ID.
We have found that the WW domain is essential for PQBP1’s
ability to drive ciliary formation in neurons. PQBP1 forms a complex via its WW domain with the GTPase Dynamin 2, attenuates
the GTPase activity of Dynamin 2, and thereby triggers ciliogenesis, potentially through regulation of the ciliary protein/membrane trafficking machinery. Importantly, the Golabi-Ito-Hall
mutation in the WW domain disrupts the PQBP1-Dynamin 2
interaction and consequent inhibition of Dynamin 2 activity,
and thus impairs the ability of PQBP1 to promote ciliogenesis
in neurons. Thus, our findings suggest that deregulation of
PQBP1-Dynamin 2 signaling in neuronal ciliogenesis may play
a role in the pathogenesis of ID. It will be important to further
explore the role of impairment of PQBP1-Dynamin 2 signaling
and ciliogenesis in the pathogenesis of ID.
Previous studies and our GST pull-down analyses revealed
that the WW domain of PQBP1 mediates interaction with various

(G) Lysates of 293T cells transfected with Dynamin 2-GFP, Dynamin 2 K44A-GFP, or Dynamin 2 DPRD-GFP were subjected to a pull-down assay with
GST-PQBP1 and immunoblotted with the GFP antibody or stained with Ponceau S.
(H) Phosphate released from GTP by Dynamin 2 was measured in the presence of GST, GST-PQBP1, GST-PQBP1 DExon4 (D98-192), GST-PQBP1 WW (1 97),
GST-PQBP1 W75AP78G, or GST-PQBP1 Y65C.
(I) The percentage of hippocampal neurons bearing a primary cilium was significantly higher at DIV3 in neurons transfected with GFP-IFT20-WW compared with
control vector, GFP-IFT20, or GFP-IFT20-WW Y65C (p < 0.01; ANOVA). A total of 387 neurons were measured.
See also Figure S4.
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Figure 5. Dynamin 2 Inhibits the Formation and Elongation of the Neuronal Cilium
(A) Lysates of 293T cells transfected with the Dynamin 2-GFP expression plasmid together with the Dynamin 2 RNAi or control Scrambled RNAi plasmid
were immunoblotted with the GFP or Erk1/2 antibody, the latter to serve as a loading control. Expression of Dynamin 2 shRNA induced knockdown of
Dynamin 2.
(B) Hippocampal neurons transfected with the Dynamin 2 RNAi or control Scrambled RNAi plasmid together with the GFP expression plasmid were subjected to
immunocytochemistry with the GFP and AC3 antibodies. Representative neurons are shown. Arrows indicate the primary cilium. Elongated cilia were observed in
Dynamin 2 knockdown neurons. Scale bar, 5 mm.
(C) The percentage of hippocampal neurons bearing a primary cilium was significantly higher in Dynamin 2 knockdown neurons as compared with control neurons
(left, p < 0.05; ANOVA). The percentage of hippocampal neurons bearing a primary cilium longer than 5 mm was significantly higher in Dynamin 2 knockdown
neurons as compared with control neurons (right, p < 0.01; ANOVA). The total of 389 neurons were measured.
(D) Hippocampal neurons were transfected with PQBP1 RNAi, Dynamin 2 RNAi, a combination of PQBP1 RNAi and Dynamin 2 RNAi, or control Scrambled RNAi
plasmid, and analyzed as in (B). The percentage of neurons bearing a primary cilium was significantly reduced in PQBP1 knockdown neurons as compared with
control neurons, and was significantly increased in Dynamin 2 knockdown neurons in the presence or absence of PQBP1 knockdown when compared with
control neurons (p < 0.05; ANOVA). A total of 487 neurons were measured.
(E) Cortical slices infected with Dynamin 2 RNAi or Scrambled RNAi lentivirus with mCitrine expression were subjected to immunohistochemistry with the GFP
and AC3 antibodies. Representative neurons are shown. Arrows indicate the primary cilium. Scale bar, 5 mm.
(legend continued on next page)
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nuclear proteins, including splicing factors (Figure 4C; Llorian
et al., 2005; Tapia et al., 2010). However, targeting the PQBP1
WW domain to the nucleus failed to promote ciliogenesis,
whereas targeting the WW domain to the cilium substantially
promoted ciliogenesis (Figure S4G). These data suggest that
PQBP1 operates at the cilium, but not in the nucleus, to promote
ciliogenesis in neurons. Whether disruption of PQBP1’s function
at the cilium contributes to the pathological mechanisms of ID
remains to be determined, since mutation of the WW domain disrupts the interaction of PQBP1 with Dynamin 2 as well as other
interaction partners (Figure 4A; Tapia et al., 2010).
Interestingly, PQBP1 binds to polyglutamine proteins and may
contribute to the pathogenesis of polyglutamine-dependent
neurodegenerative disorders (Okazawa et al., 2002; Okuda
et al., 2003). Therefore, PQBP1’s function in ciliogenesis may
also be deregulated in neurodegenerative disorders, raising
interesting parallels between developmental disorders of cognition and neurodegeneration. The PQBP1-interacting protein
Huntingtin also regulates ciliogenesis (Keryer et al., 2011; Liu
and Zeitlin, 2011; Waragai et al., 1999), raising the question of
whether PQBP1 and Huntingtin cooperate in the control of
neuronal ciliogenesis. The cytoplasmic protein Dynactin forms
a complex with PQBP1 (Kunde et al., 2011). Because Dynactin
is essential for microtubule-dependent transport and regulates
the organization of microtubules at the centrosome (Quintyne
et al., 1999), it will be interesting to determine whether Dynactin
cooperates with PQBP1 in ciliogenesis in neurons.
Identification of the signaling link between the XLID protein
PQBP1 and the GTPase Dynamin 2 illuminates a mechanism
that governs the formation of the primary cilium in postmitotic
neurons. Notably, inhibition of PQBP1 or Dynamin had little or
no effect on the morphology of the primary cilium in nonneuronal
cells, suggesting that PQBP1-Dynamin 2 signaling regulates
ciliary morphogenesis specifically in neurons.
Our study highlights a fundamental biological function for
Dynamin 2. Members of the Dynamin family of GTPases are
the subject of intense interest because of their functions in endocytosis and synaptic vesicle recycling (Murthy and De Camilli,
2003; Schmid and Frolov, 2011). The GTPase activity of Dynamins triggers membrane fission, which is critical for Dynamin’s
function in endocytosis and synaptic vesicle recycling (Schmid
and Frolov, 2011). Identification of the PQBP1-Dynamin 2
signaling link raises the question as to whether PQBP1 might
also regulate endocytosis and synaptic vesicle recycling.
Recent studies suggest that the primary cilium represents a
critical site of pathology in several developmental disorders,
including BBS, which is characterized by obesity, kidney abnormalities, and, notably, ID (Zaghloul and Katsanis, 2009). Several
proteins implicated in this syndrome form a BBSome complex
at the basal body, which regulates ciliogenesis in nonneuronal
cells (Mykytyn et al., 2004; Nachury et al., 2007). Disruption of
BBSome leads to loss of SSTR3 and MHCR1, and enrichment
of Dopamine receptor 1 at the neuronal cilium (Berbari et al.,

2008; Domire et al., 2011). Our findings raise the question as to
whether the PQBP1-Dynamin 2 pathway and the BBSome coordinately regulate ciliogenesis and ciliary receptor trafficking in
neurons. In addition, it will be interesting to test whether inhibition of Dynamin 2 by small molecules might restore ciliary development and function in XLID syndromes in which PQBP1 is
mutated, as well as in other ID syndromes that feature abnormalities in ciliary development and function. An improved understanding of the mechanisms that govern the morphogenesis of
the primary cilium in neurons should provide insights into the
pathogenesis of ID and lay the foundation for the development
of therapeutic approaches for these devastating disorders.
EXPERIMENTAL PROCEDURES
Primary Neuron Culture
Hippocampal neurons were prepared from E18 Sprague-Dawley rat embryos.
Neurons were plated on coverslips coated with poly-L-lysine (Sigma) and
cultured in Neurobasal media (Invitrogen) with B27 supplement and penicillin/streptomycin. For ciliary morphology analysis, hippocampal neurons
were transfected 16 hr after plating using a calcium phosphate method modified from that described by Konishi et al. (2004) with the indicated plasmids
together with GFP expression plasmid to visualize transfected neurons.
Immunocytochemistry
For visualization of centrosome-associated proteins, including PQBP1,
Pericentrin, and Centrin-GFP, neurons were fixed in methanol for 10 min
at 20 C and subjected to immunocytochemistry analysis. For other immunocytochemistry experiments, neurons were fixed in 4% paraformaldehyde
for 10 min at room temperature and analyzed as previously described (Konishi
et al., 2004). For double labeling with two rabbit primary antibodies, the PQBP1
antibody, and the Pericentrin or AC3 antibody, sequential staining was
performed using goat anti-rabbit Fab fragment (Jackson ImmunoResearch)
prior to the second primary antibody to eliminate cross-reactivity as previously
described (Berbari et al., 2007).
Fractionation
Nuclear and cytoplasmic fractions were prepared as previously described
(Konishi et al., 2004). Centrosomal fractions from cortical neurons were isolated as previously described (Kim et al., 2009; Puram et al., 2011).
Dynamin GTPase Activity
A colorimetric GTPase assay was performed as previously described with
modifications (Quan and Robinson, 2005). Flag-Dynamin 2 was immunopurified from lysates of 293T cells expressing Flag-Dynamin 2. Flag-Dynamin 2
(20 nM) was incubated with 0.5 mM GTP, 10 mM Tris-HCl pH7.4, 10 mM
NaCl, 2 mM MgCl2, and 0.05% Tween 80 in 20 ml at 30 C for 60 min in the
presence of 75 nM GST-PQBP1 protein. The reaction was stopped by adding
20 ml of solution containing 1 mg/ml Malachite Green oxalate, 10 mg/ml ammonium molybdate tetrahydrate, and 1 N HCl. After 5 min of incubation, absorbance at wavelength 650 nm was measured. The concentration of phosphate
generated from guanosine triphosphate (GTP) hydrolysis was calculated using
an inorganic phosphate standard curve.
In Utero Electroporation and Viral Injection
All animal surgical procedures were reviewed and approved by the Harvard
Center for Comparative Medicine. In utero electroporation was performed as
previously described (Saito, 2010). Briefly, the PQBP1 RNAi or control U6
RNAi plasmid was injected into the lateral ventricle of E15.5 mouse embryos

(F) Dynamin 2 knockdown increased the number of neurons with a cilium longer than 5 mm as compared with Scrambled control lentivirus in vivo (p < 0.05; t test).
A total of 152 neurons were measured.
(G) Model depicting the role of PQBP1 and Dynamin 2 in neuronal ciliogenesis.
See also Figure S5.
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together with the pCAG-GFP plasmid (Matsuda and Cepko, 2007). Three
pulses of electricity with 35 V for 50 ms were applied using 5 mm Tweezertrodes with an ECM830 electroporator (BTX). The electroporated mice were
sacrificed at P10. The brains were fixed and 20 mm cryosections were
prepared for immunohistochemical analyses. To eliminate potential variability
in analyses of ciliary morphology in different cortical layers, we focused our
analyses on neurons in layer 2/3 of the somatosensory cortex.
Lentivirus injection was performed as previously described (Cetin et al.,
2006). Lentivirus was produced in 293T cells and concentrated by ultracentrifuge. The lentiviral solution was injected into the brains of P1 mice with a
stereotaxic frame (Stoelting) at x (lateral) = 1 mm, y (rostral) = 1.8 mm, and z
(ventral) = 0.8 mm from Lambda. The viral solution (50 nL) was injected six
times per animal at 30 s intervals using Nanoject II (Drummond). The brains
were harvested at P10 and analyzed as described above.

Bishop, G.A., Berbari, N.F., Lewis, J., and Mykytyn, K. (2007). Type III adenylyl
cyclase localizes to primary cilia throughout the adult mouse brain. J. Comp.
Neurol. 505, 562–571.

Statistics
All analyses were performed on a minimum of three independent experiments.
Statistical analyses were performed with GraphPad Prism 4.0. All histograms
are presented as mean + SEM unless otherwise noted. Student’s t test was
used for comparisons in experiments with two sample groups. In experiments
with more than two sample groups, ANOVA was performed followed by Bonferroni’s post hoc test for pairwise comparison among three or more groups.
For further details regarding the materials and methods used in this work,
see the Extended Experimental Procedures.

Einstein, E.B., Patterson, C.A., Hon, B.J., Regan, K.A., Reddi, J., Melnikoff,
D.E., Mateer, M.J., Schulz, S., Johnson, B.N., and Tallent, M.K. (2010).
Somatostatin signaling in neuronal cilia is critical for object recognition
memory. J. Neurosci. 30, 4306–4314.
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Hamon, M., Doucet, E., Lefèvre, K., Miquel, M.C., Lanfumey, L., Insausti, R.,
Frechilla, D., Del Rio, J., and Vergé, D. (1999). Antibodies and antisense
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